Advertisement

Index by author

July 01, 1993; Volume 266,Issue 1

  1. Kamataki, T

    1. Oxidative metabolism of omeprazole in human liver microsomes: cosegregation with S-mephenytoin 4'-hydroxylation.
      K Chiba, K Kobayashi, K Manabe, M Tani, T Kamataki and T Ishizaki
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 52-59;

  2. Kanayama, T

    1. A new prostacyclin analog, KP-10614, inhibits platelet-polymorphonuclear leukocyte interaction and limits experimental infarct size in rat heart.
      T Kanayama, Y Kimura and S Mizogami
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 344-349;

  3. Karasawa, A

    1. Diuretic and renal protective effects of 8-(noradamantan-3-yl)-1,3-dipropylxanthine (KW-3902), a novel adenosine A1-receptor antagonist, via pertussis toxin insensitive mechanism.
      H Mizumoto, A Karasawa and K Kubo
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 200-206;

  4. Kauffman, R F

    1. Vascular serotonin 5-hydroxytryptamine2 receptor blockade by LY215840: lack of effect upon neointima formation in balloon-injured rat carotid arteries.
      R F Kauffman, J S Bean, W E Bloomquist and M L Cohen
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 450-455;

  5. Kimura, Y

    1. A new prostacyclin analog, KP-10614, inhibits platelet-polymorphonuclear leukocyte interaction and limits experimental infarct size in rat heart.
      T Kanayama, Y Kimura and S Mizogami
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 344-349;

  6. Klaassen, C D

    1. Oleanolic acid protects against cadmium hepatotoxicity by inducing metallothionein.
      Y Liu, H Kreppel, J Liu, S Choudhuri and C D Klaassen
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 400-406;

  7. Knoflach, F

    1. Full and partial agonism displayed by benzodiazepine receptor ligands at recombinant gamma-aminobutyric acidA receptor subtypes.
      F Knoflach, U Drescher, L Scheurer, P Malherbe and H Mohler
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 385-391;

  8. Kobayashi, K

    1. Oxidative metabolism of omeprazole in human liver microsomes: cosegregation with S-mephenytoin 4'-hydroxylation.
      K Chiba, K Kobayashi, K Manabe, M Tani, T Kamataki and T Ishizaki
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 52-59;

  9. Kohara, Y

    1. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
      Y Shibouta, Y Inada, M Ojima, T Wada, M Noda, T Sanada, K Kubo, Y Kohara, T Naka and K Nishikawa
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 114-120;

  10. Kohsaka, M

    1. Effect of FK1052, a potent 5-hydroxytryptamine3 and 5-hydroxytryptamine4 receptor dual antagonist, on colonic function in vivo.
      M Kadowaki, Y Nagakura, M Tomoi, J Mori and M Kohsaka
      Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 74-80;
« Previous (Pages : 7 8 9 10 11 12 13 14 15 16 ... 24) Next »
Back to top

In this issue

Advertisement